Equities

Renascience Inc

4889:TYO

Renascience Inc

Actions
  • Price (JPY)356.00
  • Today's Change1.00 / 0.28%
  • Shares traded20.40k
  • 1 Year change-29.78%
  • Beta--
Data delayed at least 20 minutes, as of Sep 20 2024 07:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of JPY
(except for per share items)
Fiscal data as of Mar 31 2024202420232022
ASSETS
Cash And Short Term Investments2,0272,2122,387
Total Receivables, Net4.46----
Total Inventory------
Prepaid expenses292931
Other current assets, total262610
Total current assets2,0862,2672,428
Property, plant & equipment, net04.303.63
Goodwill, net------
Intangibles, net00.180
Long term investments--0.010.01
Note receivable - long term------
Other long term assets2.362.365.03
Total assets2,0892,2752,438
LIABILITIES
Accounts payable------
Accrued expenses2.412.072.43
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total1249836
Total current liabilities12610038
Total long term debt356310199
Total debt356310199
Deferred income tax------
Minority interest------
Other liabilities, total0.000.000.00
Total liabilities482410237
SHAREHOLDERS EQUITY
Common stock1,0371,0371,037
Additional paid-in capital1,5181,5181,518
Retained earnings (accumulated deficit)(948)(690)(354)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity1,6071,8652,201
Total liabilities & shareholders' equity2,0892,2752,438
Total common shares outstanding131313
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.